GL1X · GenesisL1 explorer

UniProt P18627

Lymphocyte activation gene 3 protein (P18627)

Lymphocyte activation gene 3 protein (UniProt P18627): 8 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound, 55 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P18627
Protein
Lymphocyte activation gene 3 protein
Experimental structures
8
Predicted models
1
Ligands
2
Pockets
55 · 7 records with a druggable one

Structures

9 records of P18627 in the MolNFT archive: 8 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
7TZGStructure of human LAG3 in complex with antibody single-chain variable fragmentx-ray diffractionC, DNAG10 (best 0.71)
7TZGStructure of human LAG3 in complex with antibody single-chain variable fragmentx-ray diffractionC, DNAG10 (best 0.71)
7TZHStructure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragmentx-ray diffractionD, BNAG5 (best 0.70)
7TZHStructure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragmentx-ray diffractionD, BNAG5 (best 0.70)
7UM3Crystal structure of a Fab in complex with a peptide derived from the LAG-3 D1 domain loop insertionx-ray diffractionB, A——
8SO3CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3electron microscopyD, XNAG10 (best 0.71)
8SR0CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refinedelectron microscopyX, DNAG10 (best 0.70)
9BF9Human LAG-3-HLA-DR1 complexx-ray diffractionDNAG, SO44 (best 0.80)
P18627AlphaFold monomer V2.0 prediction for lymphocyte activation gene 3 protein (P18627)predictedA—1 (best 0.30)

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 7 records
  • SO4 · Sulfate ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.